A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents
| Image |  |
|---|---|
| Description | scientific article published on 15 November 2018 |
| Author/s |
author: Elias Jabbour Zeev Estrov Guillermo Garcia-Manero Michael Andreeff Steven M Kornblau Graciela M Nogueras-Gonzalez Courtney D DiNardo Nicholas J. Short Prithviraj Bose Kiran Naqvi Hagop Kantarjian Marina Konopleva Guillermo Montalban-Bravo Kapil Bhalla Koichi Takahashi Koji Sasaki Maria R Khouri |
| Publication date | November 15, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |